The use of adenoviral vectors in gene therapy and vaccine approaches

The use of adenoviral vectors in gene therapy and vaccine approaches

Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...

Полное описание

Библиографические подробности
Главные авторы:	Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura
Формат:	Статья
Язык:	English
Опубликовано:	Sociedade Brasileira de Genética 2022-10-01
Серии:	Genetics and Molecular Biology
Предметы:	Adenovirus gene therapy monogenic diseases cancer vaccines
Online-ссылка:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en

Схожие документы

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
по: Jingao Guo, и др.
Опубликовано: (2018-07-01)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
по: Lynda Coughlan
Опубликовано: (2020-05-01)

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
по: Luca Scarsella, и др.
Опубликовано: (2024-02-01)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
по: Rodrigo Esaki Tamura, и др.
Опубликовано: (2018-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
по: L. V. Cherenova, и др.
Опубликовано: (2017-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
по: L. V. Cherenova, и др.
Опубликовано: (2017-05-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
по: Meirong Wang, и др.
Опубликовано: (2021-03-01)

Progress in Adenoviral Capsid-Display Vaccines
по: Marija Vujadinovic, и др.
Опубликовано: (2018-07-01)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
по: Alessandra Vitelli, и др.
Опубликовано: (2017-12-01)

Adenoviral vectors for gene therapy /
по: Curiel, David T., и др.
Опубликовано: (2002)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
по: César López-Camacho, и др.
Опубликовано: (2020-06-01)

Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
по: Mirian Galliote Morale, и др.
Опубликовано: (2022-02-01)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
по: John Benest, и др.
Опубликовано: (2020-03-01)

A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates
по: José M. Rojas, и др.
Опубликовано: (2021-09-01)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
по: Vidthiya Jeyanathan, и др.
Опубликовано: (2022-06-01)

Construction and application of adenoviral vectors
по: Hongbo Zhang, и др.
Опубликовано: (2023-12-01)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
по: Qiwei Zhang, и др.
Опубликовано: (2022-03-01)

The Role of Chromatin in Adenoviral Vector Function
по: Carmen M. Wong, и др.
Опубликовано: (2013-06-01)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
по: Vidthiya Jeyanathan, и др.
Опубликовано: (2023-02-01)

Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus
по: Erika M. Petro-Turnquist, и др.
Опубликовано: (2022-06-01)

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations
по: Omar Farnós, и др.
Опубликовано: (2023-12-01)

Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route
по: Sara Afrough, и др.
Опубликовано: (2020-03-01)

Single-cycle adenovirus vectors in the current vaccine landscape
по: Michael Barry
Опубликовано: (2018-02-01)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
по: Wen-Chien Wang, и др.
Опубликовано: (2022-12-01)

Adenoviral Keratoconjunctivitis
по: Alexander Bialasiewicz
Опубликовано: (2007-04-01)

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents
по: Joshua Del Papa, и др.
Опубликовано: (2017-01-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
по: Dulce Mata-Espinosa, и др.
Опубликовано: (2023-10-01)

TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line
по: Mirian Galliote Morale, и др.
Опубликовано: (2022-04-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
по: Catherine Collignon, и др.
Опубликовано: (2020-11-01)

Developments in Viral Vector-Based Vaccines
по: Takehiro Ura, и др.
Опубликовано: (2014-07-01)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
по: Cal Koger-Pease, и др.
Опубликовано: (2023-02-01)

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes
по: Groitl Peter, и др.
Опубликовано: (2011-09-01)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
по: Andrew H. Baker, и др.
Опубликовано: (2010-10-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
по: Adam Berg, и др.
Опубликовано: (2021-10-01)

Current development in adenoviral vectors for cancer immunotherapy
по: Greyson Willis Grossman Biegert, и др.
Опубликовано: (2021-12-01)

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies
по: Chinonyerem O. Iheanacho, и др.
Опубликовано: (2022-03-01)

The prevalence of adenoviral conjunctivitis at the Clinical Hospital of the State University of Campinas, Brazil
по: Roberto Damian Pacheco Pinto, и др.
Опубликовано: (2015-11-01)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
по: Heikki Saari, и др.
Опубликовано: (2020-01-01)

Application of adenovirus vector in cancer gene therapyand vaccination
по: Xie Qian, и др.
Опубликовано: (2021-03-01)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
по: Senthil K. Chinnakannan, и др.
Опубликовано: (2020-04-01)